These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35743016)

  • 1. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.
    Ratliff M; Kim H; Qi H; Kim M; Ku B; Azorin DD; Hausmann D; Khajuria RK; Patel A; Maier E; Cousin L; Ogier A; Sahm F; Etminan N; Bunse L; Winkler F; El-Khoury V; Platten M; Kwon YJ
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
    Golebiewska A; Hau AC; Oudin A; Stieber D; Yabo YA; Baus V; Barthelemy V; Klein E; Bougnaud S; Keunen O; Wantz M; Michelucci A; Neirinckx V; Muller A; Kaoma T; Nazarov PV; Azuaje F; De Falco A; Flies B; Richart L; Poovathingal S; Arns T; Grzyb K; Mock A; Herold-Mende C; Steino A; Brown D; May P; Miletic H; Malta TM; Noushmehr H; Kwon YJ; Jahn W; Klink B; Tanner G; Stead LF; Mittelbronn M; Skupin A; Hertel F; Bjerkvig R; Niclou SP
    Acta Neuropathol; 2020 Dec; 140(6):919-949. PubMed ID: 33009951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
    Jacob F; Salinas RD; Zhang DY; Nguyen PTT; Schnoll JG; Wong SZH; Thokala R; Sheikh S; Saxena D; Prokop S; Liu DA; Qian X; Petrov D; Lucas T; Chen HI; Dorsey JF; Christian KM; Binder ZA; Nasrallah M; Brem S; O'Rourke DM; Ming GL; Song H
    Cell; 2020 Jan; 180(1):188-204.e22. PubMed ID: 31883794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of glioblastoma organoids and their applications in personalized therapy.
    Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
    Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion.
    Darrigues E; Zhao EH; De Loose A; Lee MP; Borrelli MJ; Eoff RL; Galileo DS; Penthala NR; Crooks PA; Rodriguez A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen and derivatives-based materials as substrates for the establishment of glioblastoma organoids.
    Sun L; Jiang Y; Tan H; Liang R
    Int J Biol Macromol; 2024 Jan; 254(Pt 1):128018. PubMed ID: 37967599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma.
    Lenin S; Ponthier E; Scheer KG; Yeo ECF; Tea MN; Ebert LM; Oksdath Mansilla M; Poonnoose S; Baumgartner U; Day BW; Ormsby RJ; Pitson SM; Gomez GA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
    Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO
    BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
    Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
    Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
    Loong HH; Wong AM; Chan DT; Cheung MS; Chow C; Ding X; Chan AK; Johnston PA; Lau JY; Poon WS; Wong N
    J Clin Neurosci; 2020 Aug; 78():400-402. PubMed ID: 32340843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.
    Savary C; Luciana L; Huchedé P; Tourbez A; Coquet C; Broustal M; Lopez Gonzalez A; Deligne C; Diot T; Naret O; Costa M; Meynard N; Barbet V; Müller K; Tonon L; Gadot N; Degletagne C; Attignon V; Léon S; Vanbelle C; Bomane A; Rochet I; Mournetas V; Oliveira L; Rinaudo P; Bergeron C; Dutour A; Cordier-Bussat M; Roch A; Brandenberg N; El Zein S; Watson S; Orbach D; Delattre O; Dijoud F; Corradini N; Picard C; Maucort-Boulch D; Le Grand M; Pasquier E; Blay JY; Castets M; Broutier L
    Cell Rep Med; 2023 Dec; 4(12):101339. PubMed ID: 38118405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
    Pamarthy S; Sabaawy HE
    Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing.
    Jacob F; Ming GL; Song H
    Nat Protoc; 2020 Dec; 15(12):4000-4033. PubMed ID: 33169003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of organoid technology to brain tumors.
    Wen J; Liu F; Cheng Q; Weygant N; Liang X; Fan F; Li C; Zhang L; Liu Z
    CNS Neurosci Ther; 2023 Oct; 29(10):2725-2743. PubMed ID: 37248629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-based profiling and deep learning reveal morphological heterogeneity of colorectal cancer organoids.
    Huang K; Li M; Li Q; Chen Z; Zhang Y; Gu Z
    Comput Biol Med; 2024 May; 173():108322. PubMed ID: 38554658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
    Daher A; de Groot J
    Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.